Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Alkem Laboratories Ltd. ( (IN:ALKEM) ) has provided an update.
Alkem Laboratories Ltd. has received an order from a statutory authority under the Goods and Services Tax Act, 2017, concerning a demand for GST payment and penalties related to the financial year 2020-2021. The company plans to contest the demand order, as it disagrees with the allegations of excess GST Input Tax Credit availment, and states that there is no material impact on its financial or operational activities.
More about Alkem Laboratories Ltd.
Alkem Laboratories Ltd. operates in the pharmaceutical industry, focusing on the production and distribution of generic drugs and formulations. The company is known for its extensive range of products catering to various therapeutic segments and markets both domestically and internationally.
YTD Price Performance: -15.84%
Average Trading Volume: 2,441
Current Market Cap: 556.4B INR
See more insights into ALKEM stock on TipRanks’ Stock Analysis page.